FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
S&P Global beats Q3 estimates, raises guidance, and plans divestitures amid strong ratings demand and profitability.
FIA investigates near-miss between Lawan and marshals during Mexico City Grand Prix, raising concerns about communication breakdown and safety protocols.
FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
S&P Global beats Q3 estimates, raises guidance, and plans divestitures amid strong ratings demand and profitability.
FIA investigates near-miss between Lawan and marshals during Mexico City Grand Prix, raising concerns about communication breakdown and safety protocols.
